Hamlet Protein is pleased to announce that as of October 1, 2008, its CFO, Søren Munch, has been appointed new CEO of Hamlet Protein A/S and Hamlet Protein Holding A/S. Søren Munch has a thorough understanding of and acquaintance with the soya business, also from his former position at Solae. This appointment is part of the planned generation change of the company management.
Ole Kaae Hansen, who will continue both as shareholder and as member of the board, will focus on Business Development, introducing new products and applications on the market. Furthermore, Ole Kaae Hansen will devote more time to strategic issues.
In addition and with the view to strengthen commercial operations and prepare a smooth generation change in this function, it has been decided to appoint a CCO (Chief Commercial Officer) reporting to Søren Munch.
Stephen Paul Rose continues as Sales Director and will report to the CCO, for whom the search is being initiated. A new person is hoped to be on board by the end of the year.
The financial controller, Carsten Frees, assumes the responsibility as Financial Manager.
With the above changes, Hamlet is confident that it is in position to implement its ambitious growth strategy.
